These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34003995)

  • 1. The ROCK Inhibitor Ripasudil Shows an Endothelial Protective Effect in Patients With Low Corneal Endothelial Cell Density After Cataract Surgery.
    Fujimoto H; Setoguchi Y; Kiryu J
    Transl Vis Sci Technol; 2021 Apr; 10(4):18. PubMed ID: 34003995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing.
    Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Protective Effect of Rho-Associated Kinase Inhibitor Eye Drops (Ripasudil) on Corneal Endothelial Cells After Cataract Surgery: A Prospective Comparative Study.
    Alkharashi M; Abusayf MM; Otaif W; Alkharashi A
    Ophthalmol Ther; 2024 Jun; 13(6):1773-1781. PubMed ID: 38689101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells.
    Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Functional Restoration of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy by ROCK Inhibitor (Ripasudil).
    Schlötzer-Schrehardt U; Zenkel M; Strunz M; Gießl A; Schondorf H; da Silva H; Schmidt GA; Greiner MA; Okumura N; Koizumi N; Kinoshita S; Tourtas T; Kruse FE
    Am J Ophthalmol; 2021 Apr; 224():185-199. PubMed ID: 33316261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on ripasudil for the treatment of glaucoma and ocular hypertension.
    Testa V; Ferro Desideri L; Della Giustina P; Traverso CE; Iester M
    Drugs Today (Barc); 2020 Sep; 56(9):599-608. PubMed ID: 33025953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study.
    Nakagawa H; Koizumi N; Okumura N; Suganami H; Kinoshita S
    PLoS One; 2015; 10(9):e0136802. PubMed ID: 26367375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Rho Kinase Inhibitors in Corneal Diseases.
    Futterknecht S; Chatzimichail E; Gugleta K; Panos GD; Gatzioufas Z
    Drug Des Devel Ther; 2024; 18():97-108. PubMed ID: 38264539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only.
    Macsai MS; Shiloach M
    Cornea; 2019 May; 38(5):529-534. PubMed ID: 30720541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study.
    Moloney G; Garcerant Congote D; Hirnschall N; Arsiwalla T; Luiza Mylla Boso A; Toalster N; D'Souza M; Devasahayam RN
    Cornea; 2021 Mar; 40(3):320-326. PubMed ID: 32740006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma.
    Komizo T; Ono T; Yagi A; Miyata K; Aihara M
    Jpn J Ophthalmol; 2019 Jan; 63(1):40-45. PubMed ID: 30368633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in corneal endothelial cell shape after treatment with one drop of ROCK inhibitor.
    Matsumura R; Inoue K; Shiokawa M; Ono M; Tanihara H; Ishida K; Tomita G
    Int Ophthalmol; 2020 Feb; 40(2):411-417. PubMed ID: 31664638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Use of Rho-Kinase Inhibitors has Beneficial Effect on Corneal Endothelium after Phacoemulsification.
    Alkharashi M; AlAbbasi O; Magliyah M
    Middle East Afr J Ophthalmol; 2019; 26(4):246-249. PubMed ID: 32153339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.
    Inoue T; Tanihara H
    Expert Opin Pharmacother; 2017 Oct; 18(15):1669-1673. PubMed ID: 28893104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine.
    Chihara E; Dimitrova G; Chihara T
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1257-1264. PubMed ID: 29520478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia.
    Yamaguchi M; Nakao S; Arita R; Kaizu Y; Arima M; Zhou Y; Kita T; Yoshida S; Kimura K; Isobe T; Kaneko Y; Sonoda KH; Ishibashi T
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2264-76. PubMed ID: 27124322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease.
    Syed ZA; Rapuano CJ
    Curr Opin Ophthalmol; 2021 May; 32(3):268-274. PubMed ID: 33606407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Ripasudil for the Treatment of Primary Corneal Endothelial Degeneration in Dogs.
    Michalak SR; Kim S; Park S; Casanova MI; Bowman MAW; Ferneding M; Leonard BC; Good KL; Li JY; Thomasy SM
    Transl Vis Sci Technol; 2022 Sep; 11(9):2. PubMed ID: 36048012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.
    Ohta Y; Takaseki S; Yoshitomi T
    Jpn J Ophthalmol; 2017 Sep; 61(5):423-432. PubMed ID: 28653193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study.
    Tanihara H; Kakuda T; Sano T; Kanno T; Gunji R
    BMC Ophthalmol; 2020 Jul; 20(1):275. PubMed ID: 32646383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.